C168 - Parkinson's Disease Update
Event Time: | Wednesday May 8, 2019 7:00 am to 9:00 am |
Topic(s): | Movement Disorders, Advanced Practice Provider |
Director(s): | Melissa Nirenberg MD, PhD, FAAN |
Description: | This program will provide participants with a global overview of Parkinson's disease, including the latest information about pathophysiology, genetic and environmental risk factors, biomarkers, imaging, and clinical phenomenology. Faculty will also discuss current evidence-based management of motor symptoms, nonmotor symptoms, and complications of dopaminergic therapy, including the role of new and emerging medical and surgical treatments. |
Completion Message: | Participants should have a broad understanding of Parkinson's disease, including pathophysiology, genetics, biomarkers, risk factors, motor and nonmotor symptoms, complications of dopaminergic therapy, and evidence-based medical and surgical therapies. |
CME Credits: | 2 |
Core Competencies: | Patient Care, Medical Knowledge, Practice-Based Learning and Improvement |
Start/End Time | Title | Faculty |
---|---|---|
7:00 AM - 7:50 AM | Parkinson's Disease Update: Part I | Hubert H. Fernandez MD, FAAN |
7:50 AM - 8:00 AM | Questions and Answers | Hubert H. Fernandez MD, FAAN |
8:00 AM - 8:50 AM | Parkinson's Disease Update: Part II | Melissa J. Nirenberg MD, PhD, FAAN |
8:50 AM - 9:00 AM | Questions and Answers | Melissa J. Nirenberg MD, PhD, FAAN |
Speaker | Disclosure |
---|---|
Hubert H. Fernandez, MD, FAAN | Dr. Fernandez has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with American Osteopathic Association, Cleveland Clinic, South Alabama Medical Science Foundation Thoraxx Clinical Communications, and UMA Education, as a speaker in CME events. Acorda Therapeutics, Bial Neurology, Denali Therapeutics, Pfizer, Partners Healthcare System, Parkinson Study Group, Revance, Sun Pharmaceutical Industries, Sunovion Research and Development Trust as a consultant. . Dr. Fernandez has received royalty, license fees, or contractual rights payments from Demos Publishing, Cambridge University Press. Dr. Fernandez has received research support from Abbvie, Biotie/Acorda Therapeutics, Michael J. Fox Foundation, Movement Disorders Society, NIH/NINDS, Parkinson Study Group, Rhythm, Sunovion. |
Melissa J. Nirenberg, MD, PhD, FAAN | Dr. Nirenberg has nothing to disclose. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
7:00 AM-9:00 AM |
---|
C246 -
Hot Topics and Controversies in Parkinson's Disease
Melissa Nirenberg MD, PhD, FAAN |
C247 -
What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders
Stephanie Nahas MD, FAAN |
1:00 PM-3:00 PM |
C253 -
Update in Movement Disorders
Alfonso Fasano MD, PhD |